OKYO Pharma (NASDAQ:OKYO) Trading Up 3%

OKYO Pharma Limited (NASDAQ:OKYO) was up 3% during mid-day trading on Thursday . The stock traded as high as $1.55 and last traded at $1.55. Approximately 29,798 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 145,366 shares. The stock had previously closed at $1.50.

Analysts Set New Price Targets

Separately, HC Wainwright lifted their price target on shares of OKYO Pharma from $6.00 to $7.00 and gave the stock a “buy” rating in a report on Friday, March 22nd.

OKYO Pharma Stock Down 1.6 %

The company has a fifty day moving average of $1.45 and a 200 day moving average of $1.58.

Institutional Investors Weigh In On OKYO Pharma

A hedge fund recently bought a new stake in OKYO Pharma stock. Barclays PLC purchased a new stake in shares of OKYO Pharma Limited (NASDAQ:OKYO) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 25,000 shares of the company’s stock, valued at approximately $46,000. Barclays PLC owned about 0.09% of OKYO Pharma at the end of the most recent quarter. Hedge funds and other institutional investors own 2.97% of the company’s stock.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.